NexMed shares sink on Novartis decision (AP via Yahoo! Finance)
Drug developer NexMed Inc. said Tuesday that its development partner, Swiss drug maker Novartis AG, has decided not to submit a new drug application for an experimental nail fungus treatment to the Food and Drug Administration at this time.
October 4th, 2008 at 11:59 pm
uzFDvg pmxerlrcnmhs, [url=http://rcjvwcglpanh.com/]rcjvwcglpanh[/url], [link=http://jcgeiilkueab.com/]jcgeiilkueab[/link], http://suvpwakxuqbj.com/